Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. BioMedix Vascular Solutions, Inc.
WARNING LETTER
•BioMedix Vascular Solutions, Inc.•August 6, 2008

BioMedix Vascular Solutions, Inc. – FDA Warning Letter, Aug 6, 2008

Record Details

During an FDA inspection from June 17 to August 6, 2008, BioMedix Vascular Solutions, Inc., manufacturer of the PADnet+ noninvasive cardiovascular blood flow monitoring system, was found to be in violation of Current Good Manufacturing Practice (CGMP) requirements of the Quality System (QS) regulation (21 CFR Part 820). The device is considered adulterated under section 501(h) of the Act.

Key violations include: 1. **Failure of management with executive responsibility** to ensure a fully implemented and maintained quality system (21 CFR 820.20), specifically regarding inadequate complaint handling, insufficient management reviews, un-implemented CAPA procedures, and infrequent internal quality audits. 2. **Failure to investigate complaints** involving possible device failures (21 CFR 820.198(c)), with examples cited for inaccurate measurements, incorrect data storage, irregular pressure recording, cuff inflation issues, and non-functioning devices. 3. **Failure to implement corrective and preventive action (CAPA) procedures** (21 CFR 820.100(a)), with numerous CPARs (Corrective Preventive Action Reports) not completed by due dates, not reviewed by executive management, lacking root cause investigations, and not verifying effectiveness. 4. **Failure to conduct quality audits at sufficient regular intervals** (21 CFR 820

Company
BioMedix Vascular Solutions, Inc.
Inspection date
August 6, 2008
Product type
Devices
Office
Minneapolis District Office
Person
  • Charles Becoat (Director W.)
View Company Profile

ID · 8f09a2cc-286c-437b-baea-20eca5c14d4a

Violation Codes8
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.2021 CFR 820.198(c)21 CFR 820.100(a)21 CFR 820.2221 CFR 807.97

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore BioMedix Vascular Solutions, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.